Ultralife (NASDAQ:ULBI – Get Free Report) will release its earnings data before the market opens on Friday, November 8th. Investors interested in participating in the company’s conference call can do so using this link.
Ultralife Stock Performance
Shares of ULBI stock opened at $9.02 on Wednesday. The company’s 50 day moving average is $9.27 and its 200 day moving average is $10.36. The company has a quick ratio of 2.06, a current ratio of 4.07 and a debt-to-equity ratio of 0.07. The firm has a market cap of $149.91 million, a price-to-earnings ratio of 14.79 and a beta of 0.98. Ultralife has a 52-week low of $6.36 and a 52-week high of $13.39.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Featured Articles
- Five stocks we like better than Ultralife
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Palantir Cracks $50, Is There Still Time to Get on Board?
- There Are Different Types of Stock To Invest In
- Insider Buying Signals Upside for These 3 Stocks
- Buy P&G Now, Before It Sets A New All-Time High
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.